Glycinova-GP 1mg/500mg/15mg Tablet ER

Overview Glycinova-GP 1mg/500mg/15mg Tablet ER

Combiflora-DX, a 1mg/500mg/15mg extended-release tablet, is a multi-component medication designed to manage blood glucose. In adults with type 2 diabetes, it complements diet and exercise to enhance glycemic control by optimizing insulin utilization and reducing blood sugar. Follow your physician's prescribed dosage and regimen. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; avoid doubling the dose. Excessive intake can cause hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or meal skipping may increase hypoglycemia risk; regular blood glucose monitoring is essential. Common adverse events include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or cardiac conditions to your doctor. Pregnant or lactating individuals should seek medical consultation. Baseline kidney function assessment is standard before therapy begins. Limit alcohol consumption to mitigate potential side effects.

Uses of Glycinova-GP 1mg/500mg/15mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glycinova-GP 1mg/500mg/15mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Glycinova-GP 1mg/500mg/15mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing. Consume this medication with a meal.

Common Side effects of Glycinova-GP 1mg/500mg/15mg Tablet ER:

• Hypoglycemia (low blood glucose level)
• Headache
• Nausea
• Diarrhea
• Dizziness
• Vomiting
• Anemia (low number of red blood cells)
• Weakness
• Sinus infection

How to use Glycinova-GP 1mg/500mg/15mg Tablet ER:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glycinova-GP 1mg/500mg/15mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Glycinova-GP 1mg/500mg/15mg Tablet ER works:

Glycinova-GP Extended-Release tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone – three distinct antidiabetic agents. Their synergistic action improves blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.

What if you forget to take Glycinova-GP 1mg/500mg/15mg Tablet ER :

Should you forget to take a Glycinova-GP 1mg/500mg/15mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.